Cholesterol: Significance and Regulation
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Lipid Catabolism
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Oct 10, 2025

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
Joana R Chora1, Michael A Iacocca2, Lukáš Tichý3
1Department of Health Promotion and Prevention of Noncommunicable Diseases, Nacional Institute of Health Dr. Ricardo Jorge, Lisbon, Portugal; BioISI - BioSystems & Integrative Sciences Institute, Department of Chemistry and Biochemistry, Faculty of Sciences, University of Lisbon, Lisbon, Portugal.
New guidelines optimize variant classification for Familial Hypercholesterolemia (FH) LDLR gene variants. This improves accuracy and consistency in diagnosing FH, a common genetic disorder.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: